Formulation: A 100 mg/ml solution in ethanol
Purity: ≥98%
- CAY10779
- Lipid H
- LNP-102
Xestospongin C
A membrane-
CAS No. 88903-69-9
Item No. 64950
Formulation: A clear film
Purity: ≥90%
- Araguspongine E
- XeC
Clozapine N-oxide
A metabolite of clozapine and muscarinic DREADD agonist
CAS No. 34233-69-7
Item No. 16882
Formulation: A crystalline solid
Purity: ≥98%
- CNO
(−)-
An L-glutamate analog with neuroexcitatory activities
CAS No. 58002-62-3
Item No. 78050
Formulation: A crystalline solid
Purity: ≥98%
(±)11(12)-
A racemic version of a CYP450 metabolite of arachidonic acid
CAS No. 87173-81-7
Item No. 50511
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥95%
- (±)11,12-EpETrE
Formulation: A solid
Purity: ≥98%
- TTX citrate
Formulation: A crystalline solid
Purity: ≥98%
Formulation: A crystalline solid
Purity: ≥95%
- D-
2- Amino- 5- Phosphonovaleric Acid - D-
APV
Formulation: A solid
Purity: ≥98%
- Araregai Toxin
- Maculotoxin
- Tectin
- TTX
D-
An inositol phosphate metabolite that increases intracellular calcium
CAS No. 210488-61-2
Item No. 60980
Formulation: A lyophilized powder
Purity: ≥98%
- Ins(1,3,4,5)-
P4 - 1,3,4,5-
IP4
D-
The primary intracellular IP3 receptor agonist
CAS No. 141611-10-1
Item No. 10008205
Formulation: A lyophilized powder
Purity: ≥98%
- Ins(1,4,5)P3
- 1,4,5-
IP3
Formulation: A crystalline solid
Purity: ≥98%
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥90%
- (±)17(18)-EEQ
- (±)17(18)-epoxy-5(Z),8(Z)
- (±)17(18)-epoxy-all-cis-5,8,11,14-Eicosatetraenoic Acid
- (±)17(18)-Epoxyeicosatetraenoic Acid
- 11(Z),14(Z)-ETE
- FA 20:5;O
Formulation: A crystalline solid
Purity: ≥98% (mixture of isoforms)
- Antibiotic U-
22324
Formulation: A crystalline solid
Purity: ≥98%
(±)5(6)-
A racemic version of a CYP450 metabolite of arachidonic acid
CAS No. 87173-80-6
Item No. 50211
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥95% (mixture of free acid and lactone)
- (±)5,6-
EpETrE
Gabapentin-d4
An internal standard for the quantification of gabapentin
CAS No. 1185039-20-6
Item No. 18254
Formulation: A solid
Purity: ≥95%
10,11-dihydro-10-hydroxy Carbamazepine
An antiepileptic agent and active metabolite of oxcarbazepine
CAS No. 29331-92-8
Item No. 18467
Formulation: A crystalline solid
Purity: ≥98%
- BIA 2-005
- 10,11-dihydro-10-hydroxy CBZ
- 10,11-hydroxy-10,11 Dihydrocarbamezer
- GP 47779
- Licarbazepine
Formulation: A crystalline solid
Purity: ≥98%
- VX 770
Clozapine N-
A metabolite of clozapine and muscarinic DREADD agonist
CAS No. 2250025-93-3
Item No. 25780
Formulation: A crystalline solid
Purity: ≥98%
- CNO
(±)5(6)-
A racemic version of a CYP450 pathway metabolite of arachidonic acid
CAS No. 213382-49-1
Item No. 51211
Formulation: A 100 µg/ml solution in ethanol
Purity: ≥95%
- (±)5,6-
DiHETrE
Formulation: A crystalline solid
Purity: ≥95%
Formulation: A crystalline solid
Purity: ≥98%
- AG 3-5
D-
An inositol phosphate
CAS No. 141611-11-2
Item No. 60960
Formulation: A lyophilized powder
Purity: ≥98%
- Ins(1,4,5)-
P3 (potassium salt) - 1,4,5-
IP3 (potassium salt)
Formulation: A crystalline solid
Purity: ≥98%
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
